STOCK TITAN

[Form 4] Cushman & Wakefield plc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

The Form 144 filing shows a Gevo, Inc. (GEVO) shareholder intends to sell up to 28,500 common shares through Stifel Nicolaus on Nasdaq. The block equals roughly 0.01 % of the 239,562,995 shares outstanding and carries an aggregate market value of $35,072, implying a reference price near $1.23 per share. The proposed sale date is 08/05/2025.

The shares were acquired on 08/03/2025 via restricted stock units and will be paid for in cash at settlement. The same seller, Kimberly Bowron, disposed of 35,688 shares during the prior three months for gross proceeds of $45,411. No material adverse information is asserted in the notice, and no additional company financial data are provided.

Il modulo 144 mostra che un azionista di Gevo, Inc. (GEVO) intende vendere fino a 28.500 azioni ordinarie tramite Stifel Nicolaus sul Nasdaq. Il blocco rappresenta circa lo 0,01% delle 239.562.995 azioni in circolazione e ha un valore di mercato complessivo di 35.072 dollari, con un prezzo di riferimento vicino a 1,23 dollari per azione. La data prevista per la vendita è il 05/08/2025.

Le azioni sono state acquisite il 03/08/2025 tramite unità azionarie vincolate e saranno pagate in contanti al momento della liquidazione. Lo stesso venditore, Kimberly Bowron, ha ceduto 35.688 azioni nei tre mesi precedenti per un ricavo lordo di 45.411 dollari. Nel comunicato non sono riportate informazioni negative rilevanti e non sono forniti ulteriori dati finanziari dell'azienda.

El formulario 144 muestra que un accionista de Gevo, Inc. (GEVO) tiene la intención de vender hasta 28,500 acciones comunes a través de Stifel Nicolaus en Nasdaq. El bloque equivale aproximadamente al 0,01 % de las 239,562,995 acciones en circulación y tiene un valor de mercado agregado de $35,072, lo que implica un precio de referencia cercano a $1.23 por acción. La fecha propuesta para la venta es el 05/08/2025.

Las acciones fueron adquiridas el 03/08/2025 mediante unidades de acciones restringidas y se pagarán en efectivo al momento del cierre. El mismo vendedor, Kimberly Bowron, vendió 35,688 acciones durante los tres meses anteriores por un ingreso bruto de $45,411. No se indica información adversa material en el aviso, ni se proporcionan datos financieros adicionales de la empresa.

Form 144 제출서에 따르면 Gevo, Inc. (GEVO)의 주주가 Stifel Nicolaus를 통해 나스닥에서 28,500 보통주를 매도할 예정입니다. 이 블록은 전체 발행 주식 239,562,995주의 약 0.01%에 해당하며, 총 시장 가치는 35,072달러로 주당 약 1.23달러의 기준 가격을 시사합니다. 예정된 매도일은 2025년 8월 5일입니다.

이 주식들은 2025년 8월 3일 제한 주식 단위로 취득되었으며 결제 시 현금으로 지급될 예정입니다. 동일한 판매자인 Kimberly Bowron은 지난 3개월 동안 35,688주를 매도하여 총 45,411달러의 수익을 올렸습니다. 공지에는 중요한 부정적 정보가 없으며, 추가적인 회사 재무 데이터는 제공되지 않았습니다.

Le formulaire 144 indique qu'un actionnaire de Gevo, Inc. (GEVO) prévoit de vendre jusqu'à 28 500 actions ordinaires via Stifel Nicolaus sur le Nasdaq. Ce bloc représente environ 0,01 % des 239 562 995 actions en circulation et a une valeur marchande totale de 35 072 $, ce qui implique un prix de référence proche de 1,23 $ par action. La date de vente proposée est le 05/08/2025.

Les actions ont été acquises le 03/08/2025 via des unités d'actions restreintes et seront réglées en espèces. Le même vendeur, Kimberly Bowron, a cédé 35 688 actions au cours des trois mois précédents pour un produit brut de 45 411 $. Aucune information défavorable importante n'est mentionnée dans l'avis, et aucune donnée financière supplémentaire de la société n'est fournie.

Das Formular 144 zeigt, dass ein Aktionär von Gevo, Inc. (GEVO) beabsichtigt, bis zu 28.500 Stammaktien über Stifel Nicolaus an der Nasdaq zu verkaufen. Das Paket entspricht etwa 0,01 % der 239.562.995 ausstehenden Aktien und hat einen Gesamtmarktwert von 35.072 US-Dollar, was auf einen Referenzpreis von etwa 1,23 US-Dollar pro Aktie hinweist. Das vorgeschlagene Verkaufsdatum ist der 05.08.2025.

Die Aktien wurden am 03.08.2025 durch Restricted Stock Units erworben und werden bei Abwicklung bar bezahlt. Derselbe Verkäufer, Kimberly Bowron, hat in den vorangegangenen drei Monaten 35.688 Aktien veräußert und dabei Bruttoerlöse von 45.411 US-Dollar erzielt. Im Hinweis werden keine wesentlichen negativen Informationen angegeben, und es werden keine zusätzlichen Unternehmensfinanzdaten bereitgestellt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small Form 144 sale (~0.01 % float) appears routine and is unlikely to materially impact GEVO’s valuation.

The filing registers 28,500 shares, valued at just $35k, for potential sale. With over 239 million shares outstanding, the transaction is de-minimis. The seller has gradually reduced her position—totaling 64,188 shares in three months—yet even combined proceeds remain immaterial relative to Gevo’s market cap. Absence of adverse disclosures or unusual payment terms suggests a standard liquidity event rather than a signal about fundamentals. I classify the impact on investors as neutral.

Il modulo 144 mostra che un azionista di Gevo, Inc. (GEVO) intende vendere fino a 28.500 azioni ordinarie tramite Stifel Nicolaus sul Nasdaq. Il blocco rappresenta circa lo 0,01% delle 239.562.995 azioni in circolazione e ha un valore di mercato complessivo di 35.072 dollari, con un prezzo di riferimento vicino a 1,23 dollari per azione. La data prevista per la vendita è il 05/08/2025.

Le azioni sono state acquisite il 03/08/2025 tramite unità azionarie vincolate e saranno pagate in contanti al momento della liquidazione. Lo stesso venditore, Kimberly Bowron, ha ceduto 35.688 azioni nei tre mesi precedenti per un ricavo lordo di 45.411 dollari. Nel comunicato non sono riportate informazioni negative rilevanti e non sono forniti ulteriori dati finanziari dell'azienda.

El formulario 144 muestra que un accionista de Gevo, Inc. (GEVO) tiene la intención de vender hasta 28,500 acciones comunes a través de Stifel Nicolaus en Nasdaq. El bloque equivale aproximadamente al 0,01 % de las 239,562,995 acciones en circulación y tiene un valor de mercado agregado de $35,072, lo que implica un precio de referencia cercano a $1.23 por acción. La fecha propuesta para la venta es el 05/08/2025.

Las acciones fueron adquiridas el 03/08/2025 mediante unidades de acciones restringidas y se pagarán en efectivo al momento del cierre. El mismo vendedor, Kimberly Bowron, vendió 35,688 acciones durante los tres meses anteriores por un ingreso bruto de $45,411. No se indica información adversa material en el aviso, ni se proporcionan datos financieros adicionales de la empresa.

Form 144 제출서에 따르면 Gevo, Inc. (GEVO)의 주주가 Stifel Nicolaus를 통해 나스닥에서 28,500 보통주를 매도할 예정입니다. 이 블록은 전체 발행 주식 239,562,995주의 약 0.01%에 해당하며, 총 시장 가치는 35,072달러로 주당 약 1.23달러의 기준 가격을 시사합니다. 예정된 매도일은 2025년 8월 5일입니다.

이 주식들은 2025년 8월 3일 제한 주식 단위로 취득되었으며 결제 시 현금으로 지급될 예정입니다. 동일한 판매자인 Kimberly Bowron은 지난 3개월 동안 35,688주를 매도하여 총 45,411달러의 수익을 올렸습니다. 공지에는 중요한 부정적 정보가 없으며, 추가적인 회사 재무 데이터는 제공되지 않았습니다.

Le formulaire 144 indique qu'un actionnaire de Gevo, Inc. (GEVO) prévoit de vendre jusqu'à 28 500 actions ordinaires via Stifel Nicolaus sur le Nasdaq. Ce bloc représente environ 0,01 % des 239 562 995 actions en circulation et a une valeur marchande totale de 35 072 $, ce qui implique un prix de référence proche de 1,23 $ par action. La date de vente proposée est le 05/08/2025.

Les actions ont été acquises le 03/08/2025 via des unités d'actions restreintes et seront réglées en espèces. Le même vendeur, Kimberly Bowron, a cédé 35 688 actions au cours des trois mois précédents pour un produit brut de 45 411 $. Aucune information défavorable importante n'est mentionnée dans l'avis, et aucune donnée financière supplémentaire de la société n'est fournie.

Das Formular 144 zeigt, dass ein Aktionär von Gevo, Inc. (GEVO) beabsichtigt, bis zu 28.500 Stammaktien über Stifel Nicolaus an der Nasdaq zu verkaufen. Das Paket entspricht etwa 0,01 % der 239.562.995 ausstehenden Aktien und hat einen Gesamtmarktwert von 35.072 US-Dollar, was auf einen Referenzpreis von etwa 1,23 US-Dollar pro Aktie hinweist. Das vorgeschlagene Verkaufsdatum ist der 05.08.2025.

Die Aktien wurden am 03.08.2025 durch Restricted Stock Units erworben und werden bei Abwicklung bar bezahlt. Derselbe Verkäufer, Kimberly Bowron, hat in den vorangegangenen drei Monaten 35.688 Aktien veräußert und dabei Bruttoerlöse von 45.411 US-Dollar erzielt. Im Hinweis werden keine wesentlichen negativen Informationen angegeben, und es werden keine zusätzlichen Unternehmensfinanzdaten bereitgestellt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Daimler Susan

(Last) (First) (Middle)
225 WEST WACKER DRIVE

(Street)
CHICAGO IL 60606

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cushman & Wakefield plc [ CWK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 08/01/2025 A 11,873 (2) (2) Ordinary Shares 11,873 $0 11,873 D
Explanation of Responses:
1. Restricted stock units ("RSUs") granted under the Cushman & Wakefield plc Second Amended & Restated 2018 Omnibus Non-Employee Director Share and Cash Incentive Plan convert into an equal number of ordinary shares of Cushman & Wakefield plc.
2. RSUs were granted on August 1, 2025 and vest and settle on the first anniversary of the grant date subject, with certain limited exceptions, to the reporting person's continuing board service through such vesting date.
Remarks:
/s/ Noelle J. Perkins, attorney-in-fact 08/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many GEVO shares are covered by the Form 144 notice?

28,500 common shares are proposed for sale.

What percentage of Gevo’s shares outstanding do the 28,500 shares represent?

Approximately 0.01 % of the 239,562,995 shares outstanding.

When is the proposed sale date for the shares?

The filer lists an approximate sale date of 08/05/2025.

What is the aggregate market value of the proposed sale?

The filing cites an aggregate value of $35,072.

Has the seller recently disposed of additional GEVO shares?

Yes. 35,688 shares were sold in the past three months for $45,411 total proceeds.

Which broker is facilitating the transaction?

Stifel Nicolaus & Company Inc., located at 501 N Broadway, St. Louis, MO 63102.

Does the Form 144 disclose any new adverse information about Gevo?

No. The filer states they are unaware of any non-public material adverse information.
Cushman & Wakefield Plc

NYSE:CWK

CWK Rankings

CWK Latest News

CWK Latest SEC Filings

CWK Stock Data

3.10B
228.67M
1.21%
98.86%
4.59%
Real Estate Services
Real Estate
Link
United States
LONDON